DEPARTMENT OF HEALTH
Board of OptometryRULE NO.: RULE TITLE:
64B13-18.002: Formulary of Topical Ocular Pharmaceutical AgentsPURPOSE AND EFFECT: The Board is adding the drug, Natacyn, to the formulary.
SUBJECT AREA TO BE ADDRESSED: Addition of a topical ocular pharmaceutical agent.
RULEMAKING AUTHORITY: 463.005, 463.0055(2)(a) FS.
LAW IMPLEMENTED: 463.0055 FS.IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE WEEKLY.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Bruce Deterding, Executive Director, Board of Optometry/MQA, 4052 Bald Cypress Way, Bin #C07, Tallahassee, Florida 32399-3257
THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS AVAILABLE AT NO CHARGE FROM THE CONTACT PERSON LISTED ABOVE.
Document Information
- Subject:
- Addition of a topical ocular pharmaceutical agent.
- Purpose:
- The Board is adding the drug, Natacyn, to the formulary.
- Rulemaking Authority:
- 463.005, 463.0055(2)(a) FS.
- Law:
- 463.0055 FS.
- Contact:
- Bruce Deterding, Executive Director, Board of Optometry/MQA, 4052 Bald Cypress Way, Bin #C07, Tallahassee, Florida 32399-3257.
- Related Rules: (1)
- 64B13-18.002. Formulary of Topical Ocular Pharmaceutical Agents